Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Chemoprevention with Somatuline© Delays the Progression of Pancreatic Neuroendocrine Neoplasms in a Mouse Model of Multiple Endocrine Neoplasia Type 1 (MEN1).

Lopez CL, Joos B, Bartsch DK, Manoharan J, Albers M, Slater EP, Bollmann C, Roth S, Bayer A, Fendrich V.

World J Surg. 2019 Mar;43(3):831-838. doi: 10.1007/s00268-018-4839-8.

PMID:
30600364
2.

Cooling reverses pathological bifurcations to spontaneous firing caused by mild traumatic injury.

Barlow BM, Joos B, Trinh AK, Longtin A.

Chaos. 2018 Oct;28(10):106328. doi: 10.1063/1.5040288.

PMID:
30384659
3.

Chemoprevention with Enalapril and Aspirin in Men1(+/T) Knockout Mouse Model.

Manoharan J, Fendrich V, Di Fazio P, Bollmann C, Roth S, Joos B, Mintziras I, Albers MB, Ramaswamy A, Bertolino P, Zhang CX, Slater EP, Bartsch DK, Lopez-Lopez CL.

Neuroendocrinology. 2018;107(3):257-266. doi: 10.1159/000492224. Epub 2018 Jul 19.

PMID:
30025403
4.

Chromatin Binding of c-REL and p65 Is Not Limiting for Macrophage IL12B Transcription During Immediate Suppression by Ovarian Carcinoma Ascites.

Unger A, Finkernagel F, Hoffmann N, Neuhaus F, Joos B, Nist A, Stiewe T, Visekruna A, Wagner U, Reinartz S, Müller-Brüsselbach S, Müller R, Adhikary T.

Front Immunol. 2018 Jun 27;9:1425. doi: 10.3389/fimmu.2018.01425. eCollection 2018.

5.

A model for studying the energetics of sustained high frequency firing.

Joos B, Markham MR, Lewis JE, Morris CE.

PLoS One. 2018 Apr 30;13(4):e0196508. doi: 10.1371/journal.pone.0196508. eCollection 2018.

6.

Calculating the Consequences of Left-Shifted Nav Channel Activity in Sick Excitable Cells.

Joos B, Barlow BM, Morris CE.

Handb Exp Pharmacol. 2018;246:401-422. doi: 10.1007/164_2017_63. Review.

PMID:
29030712
7.

Reply to correspondence 'Conserved signatures indicate HIV-1 transmission is under strong selection and thus is not a "stochastic" process' by Gonzalez et al., Retrovirology 2017.

Oberle CS, Magnus C, Joos B, Rusert P, Beauparlant D, Kouyos R, Trkola A, Metzner KJ, Günthard HF.

Retrovirology. 2017 Feb 24;14(1):14. doi: 10.1186/s12977-017-0332-y. No abstract available.

8.

Relaxation of a simulated lipid bilayer vesicle compressed by an atomic force microscope.

Barlow BM, Bertrand M, Joós B.

Phys Rev E. 2016 Nov;94(5-1):052408. Epub 2016 Nov 15.

PMID:
27967024
9.

The Hv1 proton channel responds to mechanical stimuli.

Pathak MM, Tran T, Hong L, Joós B, Morris CE, Tombola F.

J Gen Physiol. 2016 Nov;148(5):405-418. Epub 2016 Oct 17.

10.

Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairs.

Oberle CS, Joos B, Rusert P, Campbell NK, Beauparlant D, Kuster H, Weber J, Schenkel CD, Scherrer AU, Magnus C, Kouyos R, Rieder P, Niederöst B, Braun DL, Pavlovic J, Böni J, Yerly S, Klimkait T, Aubert V, Trkola A, Metzner KJ, Günthard HF; Swiss HIV Cohort Study (SHCS).

Retrovirology. 2016 Sep 5;13(1):62. doi: 10.1186/s12977-016-0299-0.

11.

Nav Channels in Damaged Membranes.

Morris CE, Joos B.

Curr Top Membr. 2016;78:561-97. doi: 10.1016/bs.ctm.2016.06.001. Epub 2016 Aug 2.

PMID:
27586295
12.

Endovascular Repair of a Type 1a Endoleak After Ch-EVAR with a b-EVAR.

Van den Eynde W, Van Breussegem A, Joos B, Keirse K, Verbist J, Peeters P.

Cardiovasc Intervent Radiol. 2016 Sep;39(9):1361-3. doi: 10.1007/s00270-016-1388-0. Epub 2016 Jun 6. No abstract available.

PMID:
27272712
13.

Correction: 24 Hours in the Life of HIV-1 in a T Cell Line.

Mohammadi P, Desfarges S, Bartha I, Joos B, Zangger N, Muñoz M, Günthard HF, Beerenwinkel N, Telenti A, Ciuffi A.

PLoS Pathog. 2015 Jun 15;11(6):e1005006. doi: 10.1371/journal.ppat.1005006. eCollection 2015 Jun.

14.

Mechanosensitive gating of Kv channels.

Morris CE, Prikryl EA, Joós B.

PLoS One. 2015 Feb 13;10(2):e0118335. doi: 10.1371/journal.pone.0118335. eCollection 2015. Review.

15.

A novel Acute Retroviral Syndrome Severity Score predicts the key surrogate markers for HIV-1 disease progression.

Braun DL, Kouyos R, Oberle C, Grube C, Joos B, Fellay J, McLaren PJ, Kuster H, Günthard HF.

PLoS One. 2014 Dec 9;9(12):e114111. doi: 10.1371/journal.pone.0114111. eCollection 2014.

16.

Quantifying the turnover of transcriptional subclasses of HIV-1-infected cells.

Althaus CL, Joos B, Perelson AS, Günthard HF.

PLoS Comput Biol. 2014 Oct 23;10(10):e1003871. doi: 10.1371/journal.pcbi.1003871. eCollection 2014 Oct.

17.

Stimulation-induced ectopicity and propagation windows in model damaged axons.

Lachance M, Longtin A, Morris CE, Yu N, Joós B.

J Comput Neurosci. 2014 Dec;37(3):523-31. doi: 10.1007/s10827-014-0521-9. Epub 2014 Aug 12.

18.

Membrane order parameters for interdigitated lipid bilayers measured via polarized total-internal-reflection fluorescence microscopy.

Ngo AT, Jakubek ZJ, Lu Z, Joós B, Morris CE, Johnston LJ.

Biochim Biophys Acta. 2014 Nov;1838(11):2861-9. doi: 10.1016/j.bbamem.2014.07.020. Epub 2014 Jul 26.

19.

Full-length haplotype reconstruction to infer the structure of heterogeneous virus populations.

Giallonardo FD, Töpfer A, Rey M, Prabhakaran S, Duport Y, Leemann C, Schmutz S, Campbell NK, Joos B, Lecca MR, Patrignani A, Däumer M, Beisel C, Rusert P, Trkola A, Günthard HF, Roth V, Beerenwinkel N, Metzner KJ.

Nucleic Acids Res. 2014 Aug;42(14):e115. doi: 10.1093/nar/gku537. Epub 2014 Jun 27.

20.

Next-generation sequencing of HIV-1 RNA genomes: determination of error rates and minimizing artificial recombination.

Di Giallonardo F, Zagordi O, Duport Y, Leemann C, Joos B, Künzli-Gontarczyk M, Bruggmann R, Beerenwinkel N, Günthard HF, Metzner KJ.

PLoS One. 2013 Sep 18;8(9):e74249. doi: 10.1371/journal.pone.0074249. eCollection 2013.

21.

Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection.

Metzner KJ, Scherrer AU, Preiswerk B, Joos B, von Wyl V, Leemann C, Rieder P, Braun D, Grube C, Kuster H, Böni J, Yerly S, Klimkait T, Aubert V, Furrer H, Battegay M, Vernazza PL, Cavassini M, Calmy A, Bernasconi E, Weber R, Günthard HF; Swiss HIV Cohort Study.

J Infect Dis. 2013 Oct 1;208(7):1102-12. doi: 10.1093/infdis/jit310. Epub 2013 Jul 11.

22.

24 hours in the life of HIV-1 in a T cell line.

Mohammadi P, Desfarges S, Bartha I, Joos B, Zangger N, Muñoz M, Günthard HF, Beerenwinkel N, Telenti A, Ciuffi A.

PLoS Pathog. 2013 Jan;9(1):e1003161. doi: 10.1371/journal.ppat.1003161. Epub 2013 Jan 31. Erratum in: PLoS Pathog. 2015 Jun;11(6):e1005006.

23.

Spontaneous excitation patterns computed for axons with injury-like impairments of sodium channels and Na/K pumps.

Yu N, Morris CE, Joós B, Longtin A.

PLoS Comput Biol. 2012;8(9):e1002664. doi: 10.1371/journal.pcbi.1002664. Epub 2012 Sep 13.

24.

Extrusion of small vesicles through nanochannels: a model for experiments and molecular dynamics simulations.

Bertrand M, Joós B.

Phys Rev E Stat Nonlin Soft Matter Phys. 2012 May;85(5 Pt 1):051910. Epub 2012 May 18.

PMID:
23004791
25.

Perturbed voltage-gated channel activity in perturbed bilayers: implications for ectopic arrhythmias arising from damaged membrane.

Morris CE, Juranka PF, Joós B.

Prog Biophys Mol Biol. 2012 Oct-Nov;110(2-3):245-56. doi: 10.1016/j.pbiomolbio.2012.07.003. Epub 2012 Jul 27. Review.

PMID:
22846437
26.

Coupled left-shift of Nav channels: modeling the Na⁺-loading and dysfunctional excitability of damaged axons.

Boucher PA, Joós B, Morris CE.

J Comput Neurosci. 2012 Oct;33(2):301-19. doi: 10.1007/s10827-012-0387-7. Epub 2012 Apr 5. Erratum in: J Comput Neurosci. 2012 Oct;33(2):321.

PMID:
22476614
27.

Tailored enrichment strategy detects low abundant small noncoding RNAs in HIV-1 infected cells.

Althaus CF, Vongrad V, Niederöst B, Joos B, Di Giallonardo F, Rieder P, Pavlovic J, Trkola A, Günthard HF, Metzner KJ, Fischer M.

Retrovirology. 2012 Mar 29;9:27. doi: 10.1186/1742-4690-9-27.

28.

Left-shifted nav channels in injured bilayer: primary targets for neuroprotective nav antagonists?

Morris CE, Boucher PA, Joós B.

Front Pharmacol. 2012 Feb 23;3:19. doi: 10.3389/fphar.2012.00019. eCollection 2012.

29.

Early antiretroviral therapy during primary HIV-1 infection results in a transient reduction of the viral setpoint upon treatment interruption.

Wyl Vv, Gianella S, Fischer M, Niederoest B, Kuster H, Battegay M, Bernasconi E, Cavassini M, Rauch A, Hirschel B, Vernazza P, Weber R, Joos B, Günthard HF; Swiss HIV Cohort Study-SHCS.

PLoS One. 2011;6(11):e27463. doi: 10.1371/journal.pone.0027463. Epub 2011 Nov 15.

30.

Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection.

Rieder P, Joos B, Scherrer AU, Kuster H, Braun D, Grube C, Niederöst B, Leemann C, Gianella S, Metzner KJ, Böni J, Weber R, Günthard HF.

Clin Infect Dis. 2011 Dec;53(12):1271-9. doi: 10.1093/cid/cir725. Epub 2011 Oct 12.

31.

Estimating the basic reproductive number from viral sequence data.

Stadler T, Kouyos R, von Wyl V, Yerly S, Böni J, Bürgisser P, Klimkait T, Joos B, Rieder P, Xie D, Günthard HF, Drummond AJ, Bonhoeffer S; Swiss HIV Cohort Study.

Mol Biol Evol. 2012 Jan;29(1):347-57. doi: 10.1093/molbev/msr217. Epub 2011 Sep 2.

PMID:
21890480
32.

Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA.

Gianella S, von Wyl V, Fischer M, Niederoest B, Battegay M, Bernasconi E, Cavassini M, Rauch A, Hirschel B, Vernazza P, Weber R, Joos B, Günthard HF; Swiss HIV Cohort Study.

Antivir Ther. 2011;16(4):535-45. doi: 10.3851/IMP1776.

PMID:
21685541
33.

Predictors for the emergence of the 2 multi-nucleoside/nucleotide resistance mutations 69 insertion and Q151M and their impact on clinical outcome in the Swiss HIV cohort study.

Scherrer AU, von Wyl V, Joos B, Klimkait T, Bürgisser P, Yerly S, Böni J, Ledergerber B, Günthard HF; Swiss HIV Cohort Study.

J Infect Dis. 2011 Mar 15;203(6):791-7. doi: 10.1093/infdis/jiq130. Epub 2011 Feb 1.

34.

Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection.

Kouyos RD, von Wyl V, Yerly S, Böni J, Rieder P, Joos B, Taffé P, Shah C, Bürgisser P, Klimkait T, Weber R, Hirschel B, Cavassini M, Rauch A, Battegay M, Vernazza PL, Bernasconi E, Ledergerber B, Bonhoeffer S, Günthard HF; Swiss HIV Cohort Study.

Clin Infect Dis. 2011 Feb 15;52(4):532-9. doi: 10.1093/cid/ciq164. Epub 2011 Jan 10.

35.

Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection.

Schmid A, Gianella S, von Wyl V, Metzner KJ, Scherrer AU, Niederöst B, Althaus CF, Rieder P, Grube C, Joos B, Weber R, Fischer M, Günthard HF.

PLoS One. 2010 Oct 12;5(10):e13310. doi: 10.1371/journal.pone.0013310.

36.

Entropic elasticity of dilated and contorted idealized circular chains.

Bertrand M, Forget M, Joós B.

Phys Rev E Stat Nonlin Soft Matter Phys. 2010 Jun;81(6 Pt 1):061803. Epub 2010 Jun 28.

PMID:
20866432
37.

HIV-1 transmission after cessation of early antiretroviral therapy among men having sex with men.

Rieder P, Joos B, von Wyl V, Kuster H, Grube C, Leemann C, Böni J, Yerly S, Klimkait T, Bürgisser P, Weber R, Fischer M, Günthard HF; Swiss HIV Cohort Study.

AIDS. 2010 May 15;24(8):1177-83. doi: 10.1097/QAD.0b013e328338e4de.

PMID:
20386427
38.

Disordered, stretched, and semiflexible biopolymers in two dimensions.

Zhou Z, Joós B.

Phys Rev E Stat Nonlin Soft Matter Phys. 2009 Dec;80(6 Pt 1):061911. Epub 2009 Dec 17.

PMID:
20365194
39.

Rational design of HIV-1 fluorescent hydrolysis probes considering phylogenetic variation and probe performance.

Althaus CF, Gianella S, Rieder P, von Wyl V, Kouyos RD, Niederöst B, Schmid A, Metzner KJ, Joos B, Günthard HF, Fischer M.

J Virol Methods. 2010 May;165(2):151-60. doi: 10.1016/j.jviromet.2010.01.012. Epub 2010 Jan 29. Erratum in: J Virol Methods. 2011 Apr;173(1):159.

40.

Mechanosensitive closed-closed transitions in large membrane proteins: osmoprotection and tension damping.

Boucher PA, Morris CE, Joós B.

Biophys J. 2009 Nov 18;97(10):2761-70. doi: 10.1016/j.bpj.2009.08.054.

41.

[Delayed speech development of U7--(not) a reason for concern? Results of a differential diagnostic examination of 100 children with delayed speech development].

Buschmann A, Joos B, Pietz J.

Kinderkrankenschwester. 2009 Oct;28(10):430-3. German. No abstract available.

PMID:
19886222
42.

Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients.

Gianella S, Haeberli L, Joos B, Ledergerber B, Wüthrich RP, Weber R, Kuster H, Hauser PM, Fehr T, Mueller NJ.

Transpl Infect Dis. 2010 Feb;12(1):1-10. doi: 10.1111/j.1399-3062.2009.00447.x. Epub 2009 Sep 9.

PMID:
19744285
43.

Association between specific HIV-1 Env traits and virologic control in vivo.

Joos B, Rieder P, Fischer M, Kuster H, Rusert P, Trkola A, Pillai SK, Wong JK, Weber R, Günthard HF.

Infect Genet Evol. 2010 Apr;10(3):365-72. doi: 10.1016/j.meegid.2009.06.002. Epub 2009 Jun 11.

44.

Laryngeal squamous cell carcinoma in a 13 year-old child associated with human papillomaviruses 16 and 18: a case report and review of the literature.

Joos B, Joos N, Bumpous J, Burns C, French CA, Farghaly H.

Head Neck Pathol. 2009 Mar;3(1):37-41. doi: 10.1007/s12105-008-0093-y. Epub 2008 Nov 22. Review.

45.

Biphasic decay kinetics suggest progressive slowing in turnover of latently HIV-1 infected cells during antiretroviral therapy.

Fischer M, Joos B, Niederöst B, Kaiser P, Hafner R, von Wyl V, Ackermann M, Weber R, Günthard HF.

Retrovirology. 2008 Nov 26;5:107. doi: 10.1186/1742-4690-5-107.

46.

HIV rebounds from latently infected cells, rather than from continuing low-level replication.

Joos B, Fischer M, Kuster H, Pillai SK, Wong JK, Böni J, Hirschel B, Weber R, Trkola A, Günthard HF; Swiss HIV Cohort Study.

Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16725-30. doi: 10.1073/pnas.0804192105. Epub 2008 Oct 20.

47.

Papillary glioneuronal tumor: a case report and review of the literature.

Williams SR, Joos BW, Parker JC, Parker JR.

Ann Clin Lab Sci. 2008 Summer;38(3):287-92. Review.

PMID:
18715860
48.

Sequence-dependent effects on the properties of semiflexible biopolymers.

Zhou Z, Joós B.

Phys Rev E Stat Nonlin Soft Matter Phys. 2008 Jun;77(6 Pt 1):061906. Epub 2008 Jun 9.

PMID:
18643299
49.

In vivo efficacy of human immunodeficiency virus neutralizing antibodies: estimates for protective titers.

Trkola A, Kuster H, Rusert P, von Wyl V, Leemann C, Weber R, Stiegler G, Katinger H, Joos B, Günthard HF.

J Virol. 2008 Feb;82(3):1591-9. Epub 2007 Nov 21.

50.

Stretching effects on the permeability of water molecules across a lipid bilayer.

Gauthier A, Joós B.

J Chem Phys. 2007 Sep 14;127(10):105104.

PMID:
17867783

Supplemental Content

Support Center